You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Allogeneic SCT

Showing 1 - 25 of 2,504
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

Recruiting
  • Myeloid Malignancies
  • +3 more
  • Houston, Texas
    M D Anderson Caner Center
Nov 17, 2022

GVHD Trial in Oslo (Extracorporeal photophoresis (ECP))

Completed
  • Graft-Versus-Host Disease
  • Extracorporeal photophoresis (ECP)
  • Oslo, Norway
    Tobias Gedde-Dhl
Feb 14, 2022

Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Feb 16, 2022

Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

Completed
  • Multiple Myeloma
  • allogeneic HSCT
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 1, 2022

Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

Recruiting
  • Myeloid Malignancies
  • Lymphoid Malignancies
  • NK Cell enriched-DLI only
  • NK-DLI + DUK-CPG-001
  • Durham, North Carolina
    Duke University Health System
Mar 8, 2022

DNA Methylation in Allogeneic Hematopoietic Stem Cell

Recruiting
  • Aging
  • Stem Cell Transplant Complications
    • Bologna, BO, Italy
      St.Orsola-Malpighi University Hospital
    Mar 18, 2022

    Acute Myeloid Leukemia Trial in Germany (HAM, LDAC and/or Mitoxantrone)

    Completed
    • Acute Myeloid Leukemia
    • HAM
    • LDAC and/or Mitoxantrone
    • Heidelberg, Baden-Wuerttemberg, Germany
    • +17 more
    Aug 2, 2022

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Gemtuzumab Ozogamicin
    • Valhalla, New York
      New York Medical College
    Sep 26, 2022

    Acute Myeloid Leukaemia, Myelodysplasia Trial in Birmingham (Vyxeos, Fludarabine, Busulphan)

    Recruiting
    • Acute Myeloid Leukaemia
    • Myelodysplasia
    • Birmingham, United Kingdom
      Queen Elizabeth Hospital
    Oct 14, 2021

    Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

    Active, not recruiting
    • Chronic Graft vs Host Disease
    • Chronic Graft-Versus-Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 29, 2022

    Sickle Cell Disease Trial in United States (CD34 selected T-cell depleted allogeneic SCT)

    Active, not recruiting
    • Sickle Cell Disease
    • CD34 selected T-cell depleted allogeneic SCT
    • Los Angeles, California
    • +5 more
    Sep 27, 2022

    MDS, Acute Leukemia Trial in Germany (CIK-Cells)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Acute Leukemia
    • Heidelberg, Baden-Württemberg, Germany
    • +4 more
    Mar 31, 2022

    Allogeneic Stem Cell Transplantation in Elderly: 17-years

    Completed
    • Allogeneic Stem Cell Transplantation in Elderly Patients
      • Brescia, Italy
        Chair of Hematology and Bone marrow Transplant Unit
      Jul 21, 2021

      Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)

      Not yet recruiting
      • Hematologic Diseases
      • +2 more
      • haplo-SCT with PTCy
      • (no location specified)
      Nov 8, 2021

      Graft-versus-Host Disease Trial in Cologne (Everolimus)

      Completed
      • Graft-versus-Host Disease
      • Cologne, Germany
        University of Cologne
      Mar 16, 2021

      Bone Marrow Fibrosis Trial in Germany (Allogeneic stem cell transplantation, Ruxolitinib continuous therapy)

      Active, not recruiting
      • Bone Marrow Fibrosis
      • Allogeneic stem cell transplantation
      • Ruxolitinib continuous therapy
      • Aachen, Germany
      • +13 more
      Aug 20, 2021

      Hematological Malignancies Trial in Nijmegen (MiHA-loaded PD-L-silenced DC Vaccination)

      Completed
      • Hematological Malignancies
      • MiHA-loaded PD-L-silenced DC Vaccination
      • Nijmegen, Gelderland, Netherlands
        Trialoffice Haematology-Oncology
      Mar 31, 2021

      Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

      Terminated
      Has Results
      • Acute Myeloid Leukemia (AML)
      • Allogeneic HCT
      • Consolidation chemotherapy
      • Charlotte, North Carolina
        Levine Cancer Institute
      Apr 19, 2022

      Hematopoietic Stem Cell Transplantation Trial in Nantes (IL2, Zoledronic Acid)

      Recruiting
      • Hematopoietic Stem Cell Transplantation
      • IL2
      • Zoledronic Acid
      • Nantes, France
        Nantes Uh
      Mar 29, 2022

      Allogeneic SCT for CML, TKI Failure After TKI Failure

      Unknown status
      • Chronic Myeloid Leukemia
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Oct 29, 2020

        Leukemia, Myeloid, Acute Trial in France (Ponatinib 30 MG)

        Recruiting
        • Leukemia, Myeloid, Acute
        • Ponatinib 30 MG
        • Angers, France
        • +13 more
        Aug 4, 2021

        Hematologic Malignancy Trial in Philadelphia (Maraviroc 300 mg)

        Completed
        Has Results
        • Hematologic Malignancy
        • Maraviroc 300 mg
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Dec 16, 2020

        Acute Leukemia, Myelodysplastic Syndrome Trial in Duarte (Hematopoietic Cell Transplantation, Intensity-Modulated Radiation

        Recruiting
        • Acute Leukemia
        • Myelodysplastic Syndrome
        • Hematopoietic Cell Transplantation
        • +4 more
        • Duarte, California
          City of Hope Medical Center
        Oct 7, 2022

        Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)

        Not yet recruiting
        • Acute Myeloid Leukemia in Remission
        • Nantes, Loire Atlantique, France
        • +22 more
        Jun 15, 2023

        Chronic Graft-versus-host-disease Trial in Lebanon (Ibrutinib, Rituximab)

        Terminated
        • Chronic Graft-versus-host-disease
        • Lebanon, New Hampshire
          Dartmouth-Hitchcock Medical Center
        Sep 27, 2021